From The Editor | December 16, 2020

How Biotechs Shape CDMO Capabilities


By Erin Harris, Editor-In-Chief, Cell & Gene
Follow Me On Twitter @ErinHarris_1

What You’re About to Watch

Vibalogics is headquartered in Germany and operates a fully functional CDMO facility, and the company is building a second facility in Boston. CEO Tom Hochuli and President and Managing Director Dr. Stefan Beyer answer my questions about how biotechs have helped shape the new facility’s capabilities.

Why You Should Care

Hochuli and Beyer address the current capacity of viral vectors and how the CDMO will help biotechs achieve scalability.